1. Navelbine®. Sem Oncol16(2, suppl 4): 1–41 1989
2. Binet S, Chaineau E, Fellous A, Lataste H, Krikorian A, Couzinier JP, Meininger V: Immunofluorescence study of the action of Navelbine, vincristine and vinblastine on mitotic and axonal microtubules. Int J Cancer 46:262–266, 1990
3. Depierre A, Lemarie E, Dabouis G, Garnier G, Jacoulet P, Dalphin JC: A Phase II study of Navelbine (vinorelbine) in the treatment of non-small cell lung cancer. Am J Clin Oncol (CCT) 14:115–119, 1991
4. Fernandez O, Bruno J, Mickiewicz E, Goldfarb A, Piris N, Katz A, Malzyner A, Castro C, Erazo A, Solidoro A, Otero J Carlevaro T, Lasalvia E, Noguera C, Delgado FM: Randomized comparison of Navelbine (NVB) and cisplatin (CDDP) versus NVB alone in patients with inoperable non-small cell lung cancer (NSCLC) (Abstract). Proc 15th Int Cancer Congress. J Cancer Res Clin Oncol 116 Suppl, 1990
5. LeChevalier T, Pujol JL, Douillard JY, Alberola V, Monnier A, Riviere A, Lianes P, Chomy S, Cigolari S, Berthaud P, Gottfried M, Panizo AG, Besenval M, Brisgand D: A European multicentre randomized study comparing Navelbine alonevs. Navelbine-cisplatinvs vindesine-cisplatin in 612 patients with advanced non-small cell lung cancer (NSCLC) (Abstract). Proc Annu Meet Am Soc Clin Oncol 11:A963, 1992